Envision Pharma Group today announces the appointment of Howard Miller as Chief Executive Officer. Howard previously held the position of Chief Executive Officer of Two Labs, a company acquired by Envision Pharma in November 2020.
Howard is an accomplished leader with deep sector knowledge and experience in pharma professional services having held positions at international organizations such as Abbott Laboratories, Cardinal Health and, most recently, Two Labs. He also has a proven track record in delivering sustained growth and innovation in commercialization advisory services driven by his people-first approach.
During his 15 years at Two Labs, Howard has overseen 280+ drug launches and has grown the team from <5 to over 250 employees dedicated to providing custom commercialization solutions for biopharma. As a leader, he has successfully led the acquisition and integration of both service and technology companies, the most recent of which was the 2021 acquisition of Riparian- a pharma consulting and SaaS company. It is this combination of experience and expertise that makes Howard a natural choice to lead Envision.
Together with the Executive Leadership Team, Howard will continue to lead in the delivery of Envision’s five-year plan to reinforce the Company as the tech-enabled strategic solutions partner delivering smarter, faster outcomes for the life science industry.
Howard Miller, newly appointed Chief Executive Officer of Envision Pharma Group said: “Envision has deep expertise, an outstanding reputation, and a team of 1400+ experts that truly is the best in the business, which I have had the privilege to see and experience first-hand as CEO of Two Labs.
I am excited by this opportunity to bring my experience to the wider organization and further advance our strategy in this next chapter that reinforces our continued commitment to our team and clients. I would like to thank Meg for her contributions to the continued success of Envision during her time leading the organization.”
The Board of Envision Pharma Group added: “Howard brings with him extensive knowledge and experience, not only from his tenure at Two Labs, but from across his entire career. With his authentic approach to leadership, focus on clients and commitment to accountability, he is well positioned to lead us in Envision’s next phase of growth. We express our sincere thanks to Meg for her leadership of the organisation.”
Meg Heim said: “I am proud of the accomplishments Envision has achieved during my time as CEO. We have built an organisation fit for the future with improved alignment with customer needs and have enhanced our offering to clients. I wish Howard and the Envision team continued success.”
About Envision Pharma Group
Founded in 2001, Envision Pharma Group is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies, including 19 of the top 20 pharmaceutical companies. Envision supports clients across the product life cycle through a comprehensive suite of services and industry-leading technology solutions that include artificial intelligence and natural language processing, commercialization and integrated strategic consulting, evidence-based scientific communications and engagement, HEOR/market access and data analytics, medical capabilities, and omnichannel solutions. Learn more at www.envisionpharmagroup.com.